Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Jan 9;120(1):e20220248.
doi: 10.36660/abc.20220248. eCollection 2023.

Revascularization with Coronary Artery Bypass Grafting in Non-ST-elevation Acute Coronary Syndromes: A Snapshot of Randomized Trials and Registries

[Article in English, Portuguese]
Josip Andelo Borovac  1 , Jerko Ferri-Certic  2 , Dino Miric  1 , Jaksa Zanchi  1 , Mislav Lozo  1 , Anteo Bradaric  1 , Konstantin Schwarz  3 , Chun Shing Kwok  4
Affiliations

Revascularization with Coronary Artery Bypass Grafting in Non-ST-elevation Acute Coronary Syndromes: A Snapshot of Randomized Trials and Registries

[Article in English, Portuguese]
Josip Andelo Borovac et al. Arq Bras Cardiol. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

Potencial conflito de interesse

Não há conflito com o presente artigo.

Figures

Figura Central
Figura Central. Revascularização com Bypass Coronário em Síndromes Coronarianas Agudas sem Supradesnivelamento do Segmento ST: Uma Instantânea de Ensaios e Registros Randomizados
Figura 1
Figura 1. Gráfico de bolhas mostrando a proporção (%) de pacientes com SCASSST tratados com ICP ou CRVM após angiografia diagnóstica em estudos observacionais e ensaios clínicos randomizados (ECR), estratificados por tamanho do estudo. CRVM: cirurgia de revascularização do miocárdio
Figura 2
Figura 2. Uma figura resumindo, mostrando a distribuição ponderada das estratégias de manejo (ICP, CRVM, TMO) e características dos pacientes de alto risco, incluindo insuficiência renal, disfunção ventricular esquerda ou insuficiência cardíaca, diabetes mellitus e doença triarterial e/ou de tronco esquerdo entre pacientes com infarto do miocárdio sem supradesnivelamento do segmento. VE: ventrículo esquerdo; CVRM: cirurgia de revascularização do miocárdio; TMO: terapia médica ideal; ICP: intervenção coronária percutânea; ECR: ensaios clínicos randomizados.
Central Illustration
Central Illustration. Revascularization with Coronary Artery Bypass Grafting in Non-STelevation Acute Coronary Syndromes: A Snapshot of Randomized Trials and Registries
Figure 1
Figure 1. A bubble plot showing the proportion (%) of patients with NSTE-ACS treated with PCI or CABG after diagnostic angiography in observational studies and randomized controlled trials (RCTs), stratified by study size. CABG: coronary artery bypass graft.
Figure 2
Figure 2. A summarizing figure showing the weighted distribution of management strategies (PCI, CABG, OMT) and high-risk patient characteristics, including renal failure, left ventricular dysfunction or heart failure, diabetes mellitus and three-vessel and/or left main disease among patients with NSTE-ACS. CABG: coronary artery bypass graft; NSTE-ACS: non-ST-elevation myocardial infarction; OMT: optimal medical therapy; PCI: percutaneous coronary intervention.
See this image and copyright information in PMC

References

    1. Collet JP, Thiele H, Barbato E, Barthélémy O, Bauersachs J, Bhatt DL, et al. 2020 ESC Guidelines for the Management of Acute Coronary Syndromes in Patients Presenting Without Persistent ST-segment Elevation. Eur Heart J . 2021;42(14):1289–1367. doi: 10.1093/eurheartj/ehaa575. - DOI - PubMed
    1. Montalescot G, Bolognese L, Dudek D, Goldstein P, Hamm C, Tanguay JF, et al. Pretreatment with Prasugrel in non-ST-segment Elevation Acute Coronary Syndromes. N Engl J Med . 2013;369(11):999–1010. doi: 10.1056/NEJMoa1308075. - DOI - PubMed
    1. Schüpke S, Neumann FJ, Menichelli M, Mayer K, Bernlochner I, Wöhrle J, et al. Ticagrelor or Prasugrel in Patients with Acute Coronary Syndromes. N Engl J Med . 2019;381(16):1524–1534. doi: 10.1056/NEJMoa1908973. - DOI - PubMed
    1. Dworeck C, Redfors B, Angerås O, Haraldsson I, Odenstedt J, Ioanes D, et al. Association of Pretreatment With P2Y12 Receptor Antagonists Preceding Percutaneous Coronary Intervention in Non-ST-Segment Elevation Acute Coronary Syndromes With Outcomes. JAMA Netw Open . 2020;3(10):e2018735. doi: 10.1001/jamanetworkopen.2020.18735. - DOI - PMC - PubMed
    1. Valina C, Neumann FJ, Menichelli M, Mayer K, Wöhrle J, Bernlochner I, et al. Ticagrelor or Prasugrel in Patients With Non-ST-Segment Elevation Acute Coronary Syndromes. J Am Coll Cardiol . 2020;76(21):2436–2446. doi: 10.1016/j.jacc.2020.09.584. - DOI - PubMed